JP6310977B2 - Nail seal and seal sheet - Google Patents

Description

  The present invention relates to a seal sheet having a plurality of nail seals and nail seals.

  In recent years, an artificial nail (artificial nail) that can be attached to fingers and toes to make a fingertip look beautiful has been proposed (Patent Document 1). In addition, a seal that can be decorated by sticking to a nail has been proposed (Patent Document 2).

Utility Model Registration No. 3199104 Japanese Utility Model Publication No. 1-262705

  On the other hand, in recent years, it is said that elderly people suffer from onychomycosis at a rate of 1 out of 4 people. Onychomycosis is often not treated until it becomes severe and severe. In addition, when onychomycosis becomes severe, it is accompanied by pain due to deformation of the nail. Furthermore, when onychomycosis affecting the toes becomes severe, there is a risk of difficulty in walking.

  Conventionally, for treatment of onychomycosis, internal medicine and external medicine have been applied. However, since the treatment for onychomycosis burdens the liver and kidneys, it cannot be taken by elderly people with a history of liver disease or kidney disease. Further, in the application of the medicine, since the medicine is applied to the nail, it takes time for the medicine to penetrate into the affected area. Furthermore, the applied drug may be washed away by bathing or the like, and the medicinal effect may not be obtained.

  The present invention has been made in view of such circumstances, and provides a nail seal or the like capable of effectively penetrating a nail and preventing the drug from being washed away. Objective.

The nail seal according to the present invention comprises a sheet-like main body, an adhesive layer provided on the lower surface of the main body, an outer shell formed of a sheet or a film, and a drug held inside the outer shell. A plurality of holding portions, a plurality of protrusions having a tapered shape, a root portion bonded to the adhesive layer, and having a hole portion at a tip portion , and each of the plurality of protrusion portions is provided inside the root portion. The holding portion is housed in the housing .

  In the present invention, since the medicine is held by the holding portion and the medicine flows out from the tip of the projection, a certain amount of the medicine can be reliably supplied to the surface of the nail.

  The nail seal according to the present invention has a crescent shape in plan view.

  In the present invention, by making the artificial nail into a crescent shape in plan view, it becomes possible to cope with an early stage of onset in which only the tip of the nail is an affected part.

  The nail seal according to the present invention is characterized in that an adhesive is applied to only a part of the adherend surface.

  In the present invention, by applying an adhesive to a part of the adherend surface, the nail seal with no medicinal effect can be easily peeled off from the nail.

  In the nail seal according to the present invention, the adherend surface is composed of a plurality of regions, and adhesives having different adhesive forces are applied to each region.

  In the present invention, by applying pressure-sensitive adhesives having different adhesive forces to the adherend surface, it is difficult to peel off during use, and it is possible to easily peel off when peeling off.

  The seal sheet according to the present invention has a sheet shape and has a plurality of any of the above-described nail seals.

  In the present invention, by combining a plurality of nail seals, it is possible to cope with individual differences in the sizes of a plurality of fingers and nails.

  The seal sheet according to the present invention includes a recording unit that records a use start date of the nail seal.

  In the present invention, it is possible to easily grasp the replacement time of the artificial nail after the period during which the medicinal effect is obtained by entering the use start date in the recording unit.

  In the present invention, since the nail surface is covered by sticking the nail seal containing the drug on the adherend surface to prevent the drug from being washed away, the drug is effective to the affected area. Infiltration.

It is explanatory drawing which shows an example of an artificial nail. It is sectional drawing by the II-II line of FIG. It is sectional drawing which shows the other example of the artificial nail. It is a perspective view which shows an example of an artificial nail. It is sectional drawing by the VV line of FIG. It is a perspective view which shows an example of an artificial nail. It is a top view which shows the state which adhered the nail | claw to the nail | claw. It is a top view which shows an example of an artificial nail set. It is a perspective view which shows the example of the sealing sheet containing the seal | sticker for nail | claws. It is sectional drawing by the XX sectional line of FIG. It is sectional drawing which shows an example of the seal | sticker for nail | claws. It is sectional drawing which shows an example of the seal | sticker for nail | claws. It is a partial expanded sectional view which shows a mode that the seal | sticker for nail | claw was pressed down. It is a top view which shows an example of the seal | sticker for nail | claws. It is a top view which shows an example of the seal | sticker for nail | claws. It is a top view which shows an example of the seal | sticker for nail | claws. It is a top view which shows the structural example of the seal | sticker set for nails. It is a top view which shows the structural example of the seal | sticker set for nails.

Embodiment 1
Hereinafter, embodiments will be specifically described with reference to the drawings. FIG. 1 is an explanatory diagram showing an example of an artificial nail 1. FIG. 1A is a perspective view showing only the artificial nail 1. FIG. 1B is a plan view showing a state in which the artificial nail 1 is attached to a nail having an affected part. 2 is a cross-sectional view taken along line II-II in FIG. The cross section in the direction intersecting the longitudinal direction of the artificial nail 1 has an arch shape. The artificial nail 1 has a shape imitating a human nail.

  The artificial nail 1 has a two-layer structure including a main body layer 11 and a drug layer 12 laminated in the thickness direction. The main body layer 11 plays a role of preventing water from splashing on the surface of the nail N having an affected part and suppressing the flow of medicines such as external medicines. The main body layer 11 is formed of a hard and water-impermeable synthetic resin, for example, an acrylic resin. The main body layer 11 may be formed of a water-permeable resin, and a non-water-permeable resin film may be attached to the surface.

  The drug layer 12 is formed over the entire back surface of the main body layer 11, that is, the entire surface to be attached to the nail. The drug layer 12 is obtained by impregnating a base material obtained by forming a porous material into a sheet shape with a drug such as an external medicine for onychomycosis. The porous material is formed by mixing a foaming agent with a synthetic resin material such as urethane. When the artificial nail 1 is fixed (attached) to the affected nail N, an appropriate adhesive is applied to a plurality of locations on the drug layer 12 and then fixed to the nail surface. In addition, before using the artificial nail 1, a sheet material that does not transmit medicine, water, dust, or the like may be attached to the surface of the drug layer 12 in order to protect the surface of the drug layer 12.

  The drug is, for example, a solution containing efinaconazole or terbinafine hydrochloride, a suspension / emulsion, an ointment and the like. Since the adhesive contains a drug, a material that does not cause a chemical reaction with the drug is selected. Moreover, although the well-known thing can be used for an adhesive, what has biocompatibility is desirable.

  The drug layer 12 may be formed not on the entire back surface of the main body layer 11 but on a part of the back surface. When the drug layer 12 is provided on a part of the back surface of the main body layer 11, it may be provided at a plurality of discontinuous locations. Further, an adhesive or a pressure-sensitive adhesive may be included in the base material of the drug layer 12. In this case, when the artificial nail 1 is attached to the nail N, it is not necessary to apply an adhesive or a pressure-sensitive adhesive. Alternatively, only a small amount of adhesive or pressure-sensitive adhesive may be applied.

  The first embodiment has the following effects. Since the artificial nail 1 having the drug layer 12 containing the drug is fixed to the nail N affected by the affected area, the drug can be effectively penetrated into the nail N of the affected area. Since the main body layer 11 is provided, it is possible to prevent the drug from being melted or washed away even when it is splashed with water, so that the drug can penetrate into the affected area. And it becomes possible to acquire the medicinal effect of a chemical | medical agent.

Embodiment 2
The artificial nail 1 in the second embodiment relates to a form in which the drug layer 12 has a protrusion. In the following description, differences from the first embodiment will be mainly described, and description of points that are the same as those of the first embodiment will be omitted.

  FIG. 3 is a cross-sectional view showing another example of the artificial nail 1. FIG. 3A shows a cross section similar to that of FIG. In addition to the main body layer 11 and the drug layer 12, the artificial nail 1 in the second embodiment further includes a protrusion 13. The protrusion 13 is formed integrally with the main body layer 11. The protruding portion 13 has a cone shape such as a cone shape or a triangular pyramid shape. The protrusion 13 is made to contain a drug by a method such as application and impregnation on the surface.

  FIG. 3B is a partially enlarged cross-sectional view showing a state in which the artificial nail 1 is fixed to the nail N. As shown in FIG. 3B, when the artificial nail 1 is fixed to the nail N, the portion of the drug layer 12 having the protrusion 13 is contracted and deformed. The protrusion 13 is pressed against the nail N by the restoring force of the contracted and deformed portion. In this embodiment as well, an adhesive or a pressure-sensitive adhesive is used when attaching the artificial nail 1 to the nail N, but the description is omitted in FIG. 3B.

  In the second embodiment, in addition to the effects of the first embodiment, the following effects can be obtained. By providing the protruding portion 13, a slight scratch is generated on the surface of the nail N, and the drug easily penetrates into the nail N.

  In addition, when it is possible to include the chemical | medical agent sufficient for the medicinal effect in the protrusion part 13, the chemical | medical agent layer 12 is good also as an adhesive layer which has adhesiveness.

Embodiment 3
The artificial nail 1 in Embodiment 3 relates to a form having a holding part for holding a medicine. In the following description, differences from the other embodiments will be mainly described, and description of points that are the same as those of the other embodiments will be omitted.

  FIG. 4 is a perspective view showing an example of the artificial nail 1. FIG. 5 is a cross-sectional view taken along line VV in FIG. FIG. 5 shows a cross section of the artificial nail 1. The artificial nail 1 includes a main body layer 11, a protruding portion 13, a medicine holding portion 14, and an adhesive layer 15. The medicine holding part 14 is provided on the lower side of the main body layer 11 (side closer to the nail when attached) so as to form a space. The medicine holding part 14 has a size slightly smaller than the main body layer 11. The protruding portion 13 protrudes downward from the medicine holding portion 14. The protrusion 13 has a cone shape. The protrusion 13 is provided with a drug introduction path 131 that communicates with the drug holding unit 14 at the base and reaches the tip. The adhesive layer 15 is provided on the lower side of the medicine holding part 14 and avoiding the protrusion 13 so as not to block the medicine introduction path 131. An adhesive layer 15 is also provided on the inner side of the main body layer 11 where the medicine holding part 14 is not provided.

  The artificial nail 1 is fixed to the nail having the affected part by the adhesive layer 15. When the artificial nail 1 is fixed to the nail, the tip of the protrusion 13 is in close contact with the nail so as to apply a predetermined pressure. The medicine holding unit 14 holds a liquid medicine inside. The drug flows into the drug introduction path 131 from the root of the drug introduction path 131 communicating with the drug holding unit 14. The inflowing medicine flows through the medicine introduction path 131 toward the tip, and is discharged from the tip portion in contact with the nail. The discharged medicine penetrates into the nail N in the affected area.

  In the third embodiment, the medicine is held by the medicine holding unit 14 and discharged from the tip of the protrusion 13. This makes it possible to continuously supply a stable amount of medicine to the nail that is the affected part.

Embodiment 4
The fourth embodiment relates to a form in which the artificial nail 1 has a crescent shape in plan view. FIG. 6 is a perspective view showing an example of the artificial nail 1. The artificial nail 1 includes a main body layer 11 and a drug layer 12 as in the other embodiments. FIG. 7 is a plan view showing a state in which the artificial nail 1 is attached to the nail. As shown in FIG. 7, the artificial nail 1 of the present embodiment can be easily attached to the tip of the nail N by having a crescent shape in plan view. Since onychomycosis develops from the tip of the nail N, it can be treated at an early stage.

Embodiment 5
Embodiment 5 relates to an artificial nail set in which a plurality of artificial nails 1 are combined. FIG. 8 is a plan view showing an example of the artificial nail set 10. The artificial nail set 10 is a combination of five artificial nails 1. Each artificial nail 1 has the same shape and the same size. Since it takes several months until the onychomycosis is completely cured, it is effective to combine a plurality of artificial nails 1.

  As shown in FIG. 8, five artificial claws 1 are housed in a case 2. The case 2 has a rectangular box with a partition so that the five artificial nails 1 constituting the artificial nail set 10 can be individually accommodated. The top surface of the case 2 has an opening substantially on the entire surface, but a part of the entry portion 21 that is parallel to the bottom surface and has a plate shape is provided. The entry unit 21 includes delimited entry areas 21a to 21e. Each of the entry areas 21 a to 21 e corresponds to each of the five artificial nails 1. The entry areas 21a to 21e are provided for entering the date on which each of the five artificial nails 1 is started to be used. By filling in the start date of use, it is possible to easily grasp the replacement time of the artificial nail 1 after the period during which the medicinal effect is obtained.

Embodiment 6
The sixth embodiment relates to a nail seal. FIG. 9 is a perspective view showing an example of a seal sheet including the nail seal 3. 10 is a cross-sectional view taken along the line XX of FIG. The nail seal 3 before use is affixed to the seal mount 4.

  The nail seal 3 includes a protective layer 31, a main body layer 32, and a drug layer 33. The protective layer 31 has a thin transparent film shape. The protective layer 31 protects the nail seal 3 from moisture and the like. The protective layer 31 is formed of a transparent resin such as polypropylene, polyester, or PET (polyethylene terephthalate). The main body layer 32 is made of paper such as high-quality paper, art paper, and craft paper. The main body layer 32 may be formed of a resin film instead of paper. The drug layer 33 includes a drug and an adhesive. The nail seal 3 has a mounting surface on the drug layer 33 side. The seal mount 4 includes a release layer (not shown) formed of a silicone resin or the like on the surface so that the nail seal 3 can be easily peeled off.

  The nail seal 3 configured as described above is used as follows. The user peels off the nail seal 3 from the seal mount 4 and attaches the nail seal 3 along the curved surface of the nail having the affected part. Since the drug layer 33 of the nail seal 3 contains an adhesive, the nail seal 3 is fixed to the nail by the adhesive.

  The nail seal 3 of the sixth embodiment has the following effects. Since the drug layer 33 contains a drug for treating onychomycosis, the drug can penetrate into the affected area through the nail and obtain a medicinal effect. Moreover, since the nail | claw seal | sticker 3 is a sheet form, it can be stuck along the curved surface of a nail | claw. Furthermore, since the nail seal 3 has a sheet shape, the nail seal 3 can be adjusted to a shape suitable for the nail by cutting with a scissor or a cutter.

Embodiment 7
The seventh embodiment relates to a configuration including a protrusion. FIG. 11 is a cross-sectional view showing an example of the claw seal 3. The nail seal 3 includes a protective layer 31, a main body layer 32, a drug layer 33, and a protrusion 35. The nail seal 3 is affixed to the seal mount 4 before the start of use. Since the structure of the protective layer 31 and the main body layer 32 is the same as that of Embodiment 6, description is abbreviate | omitted.

  The drug layer 33 includes a drug and an adhesive made of a material that does not cause a chemical reaction with the drug. The adhesive is desirably biocompatible. The protrusion 35 has a cone shape such as a cone shape. The protrusion 35 is provided so as to protrude downward from the drug layer 33 (side toward the nail during use). The protrusion 35 is formed of a material harder than the drug layer 33. As shown in FIG. 11, in a state where the nail seal 3 is attached to the seal mount 4, the portion of the drug layer 33 to which the protrusion 35 is fixed is pressed against the protrusion 35 and is thicker than the other portions. Is getting thinner.

  As in the sixth embodiment, the nail seal 3 according to the present embodiment is peeled off from the sticker mount 4 and attached to a nail having an affected part. When the nail seal 3 is affixed to the nail, the protrusion 35 is more elastic than the drug layer 33 embedded in the adhesive layer 34 as shown in FIG. It will be pressed.

  The nail seal 3 of the seventh embodiment has the following effects in addition to the effects of the sixth embodiment. By providing the protrusion 35, the surface of the nail is slightly scratched. Thereby, the medicine easily penetrates into the nail, and the medicinal effect is more easily obtained. In the present embodiment, a drug may be included in the protrusion 35, and an adhesive layer that does not include a drug may be used instead of the drug layer 33.

Embodiment 8
Embodiment 8 relates to a form having a drug holding part for holding a drug. FIG. 12 is a cross-sectional view showing an example of the claw seal 3. The nail seal 3 includes a protective layer 31, a main body layer 32, an adhesive layer 34, a protruding portion 35, and a medicine holding portion 36. The nail seal 3 is affixed to the seal mount 4 before the start of use. About the protective layer 31, the main body layer 32, the adhesion layer 34, and the seal | sticker mount 4, since it is the same as that of other embodiment, description is abbreviate | omitted.

  The protrusion 35 has a truncated cone shape such as a truncated cone shape. The protruding portion 35 is provided so as to protrude downward from the adhesive layer 34 (side toward the nail during use). The protrusion 35 is hollow and has a hole at the tip. The protrusion 35 has a medicine holding part 36 inside. The medicine holding part 36 has a spherical shape or a polyhedral shape. The medicine holding unit 36 includes an outer shell formed of a sheet or a film and a medicine stored inside. The medicine holding part 36 is provided at the base of the protrusion part 35 (part close to the adhesive layer 34).

  As in the sixth embodiment, the nail seal 3 according to the present embodiment is peeled off from the sticker mount 4 and attached to a nail having an affected part. After the nail seal 3 is attached to the nail and fixed, the entire surface of the nail seal 3 is further pressed against the nail. FIG. 13 is a partially enlarged cross-sectional view showing a state where the nail seal 3 is pressed. FIG. 13A shows a state before being pressed, and FIG. 13B shows a state when pressed. Since the protruding portion 35 has a truncated cone shape, the protruding portion 35 is tapered toward the nail N side from the base portion close to the adhesive layer 34. The medicine holding part 36 is sized to fit in the base of the protruding part 35. Therefore, as shown in FIG. 13A, the medicine holding part 36 cannot move toward the tip of the projection part 35. In this state, when the user sequentially presses a part of the surface of the nail seal 3 attached to the nail and finishes pressing the entire surface of the nail seal 3, the state shown in FIG. 13B is obtained. In the nail seal 3, when the surface of the portion where the protrusion 35 is provided is pressed, the protective layer 31, the main body layer 32, and the adhesive layer 34 are pressed downward (nail N direction) and deformed. Thereby, the medicine holding part 36 is also pressed down. However, since the protruding portion 35 is tapered, the medicine holding portion 36 remains in place and the whole is deformed. Then, when a force of a certain level or more is applied, a hole is opened in the outer shell so as to rupture, and the medicine inside flows out toward the tip of the projection 35. The medicine that has flowed out reaches the nail N and penetrates into the nail.

  The nail seal 3 of the eighth embodiment has the following effects in addition to the effects of the other embodiments. By providing the protrusion 35, the surface of the nail is slightly scratched. Thereby, the medicine easily penetrates into the nail, and the medicinal effect is more easily obtained. Further, by providing the medicine holding part 36, a certain amount of medicine can be reliably supplied to the surface of the nail N. Thereby, medicinal effects can be obtained. Also in this embodiment, instead of the adhesive layer 34, an adhesive layer in which a drug and an adhesive are mixed may be used.

Embodiment 9
The ninth embodiment relates to a form in which the nail seal 3 has a crescent shape in plan view. FIG. 14 is a plan view showing an example of the claw seal 3. As shown in FIG. 14, the nail seal 3 has a crescent shape in plan view. Since other configurations are the same as those of the other embodiments, the description thereof is omitted.

  In the present embodiment, the nail seal 3 is attached to the tip of the nail of the affected part. Thereby, it is possible to treat onychomycosis at an early stage where the tip of the nail becomes an affected area.

Embodiment 10
The tenth embodiment relates to a form in which the drug layer 33 is provided not on the entire surface of the main body layer but on a part of the surface. Since other configurations are the same as those of the other embodiments, different points will be mainly described in the following description. FIG. 15 is a plan view showing an example of the claw seal 3. The nail seal 3 is affixed to a seal mount 4 before use. The shape of the drug layer 33 in plan view is similar to the outer shape of the nail seal 3 and is smaller than the outer shape of the nail seal 3. That is, the drug layer 33 of the nail seal 3 is not provided on the entire attachment surface of the nail seal 3. The drug layer 33 containing an adhesive is not provided on the outer edge of the nail seal 3. Thereby, there is an effect that the nail seal 3 is easily peeled off. In addition, if the area where the drug layer 33 including the adhesive is provided is too small, the nail seal 3 is likely to be peeled off in a scene not intended by the user, so the area ratio between the surface where the drug layer 33 is provided and the surface where the drug layer 33 is not provided. Adjust as appropriate.

Embodiment 11
Embodiment 11 relates to a form in which a plurality of drug layers 331 and 332 having different adhesiveness are provided. Since other configurations are the same as those of the other embodiments, different points will be mainly described in the following description. FIG. 16 is a plan view showing an example of the claw seal 3. The nail seal 3 is affixed to a seal mount 4 before use. As shown in FIG. 16, two drug layers 331 and 332 are provided on the attachment surface of the nail seal 3. The drug layer 331 has a shape that matches the outer shape of the nail seal 3. The drug layer 332 is formed inside the drug layer 331 and has a rectangular shape in plan view. The two drug layers 331 and 332 include an adhesive and a drug. One drug layer 332 is provided on the periphery of another drug layer 331. One drug layer 332 has a lower adhesive strength than the other drug layers 331. Thereby, it is difficult to peel off when the nail seal 3 is used, but it is possible to obtain both the conflicting effects that it is easy to peel off from the nail. The adhesiveness of the drug layer may be changed in multiple stages. For example, the corresponding portion of the toe may have the strongest adhesive force, and the adhesive force may be weakened as it approaches the hairline of the nail. If the nail seal 3 is cut as the nail stretches, the strong adhesive portion gradually decreases with the passage of time, and the nail seal 3 is easily peeled off when the replacement time comes. Moreover, you may provide the part in which neither of the chemical | medical agent layers 331 and 332 is provided in a part of attachment surface of the seal | sticker 3 for nail | claws. Furthermore, any one of the two drug layers 331 and 332 may be an adhesive layer that does not contain a drug.

Embodiment 12
The twelfth embodiment relates to a form provided with a plurality of the nail seals 3 described above. FIG. 17 is a plan view showing a configuration example of the nail seal set. The nail seal set includes five nail seals 3. Each of the five claw seals 3 is the same as any one of the claw seals 3 described above, and a detailed description thereof will be omitted. Each claw seal 3 has the same shape and the same size. Since it takes several months until the onychomycosis is completely cured, it is effective to combine a plurality of nail seals 3. Each nail seal 3 is affixed to a seal mount 4 before use. The seal mount 4 is provided with entry areas 41a to 41e corresponding to the nail seals 3 respectively. In the entry areas 41a to 41e, the date when the nail seal 3 is started to be used is entered. By entering the start date of use, it becomes possible to easily grasp the replacement time of the nail seal 3 after the period during which the medicinal effect is obtained.

Embodiment 13
The thirteenth embodiment relates to a form in which a seal not containing a drug is combined in a nail seal set. FIG. 18 is a plan view showing a configuration example of the nail seal set. The nail seal set is made up of a total of 10 sheets including 5 sheets of nail seals 3a1 to 3e1 and 5 sheets of nail seals 3a2 to 3e2. Each of the claw seals 3a1 to 3e1, 3a2 to 3e2 has the same configuration as any of the claw seals 3 described above. The nail seals 3a1 and 3a2 are for the thumb. The nail seals 3b1 and 3b2 are for the index finger. The nail seals 3c1 and 3c2 are for the middle finger. The nail seals 3d1 and 3d2 are for the ring finger. The nail seals 3e1 and 3e2 are for little fingers. As described above, by setting a plurality of artificial nails as a set, it becomes possible to cope with individual differences in the sizes of the fingers and the nails.

  The nail seals 3a1 to 3e1 are seals containing a medicine. The nail seals 3a2 to 3e2 are seals that do not contain a medicine. In the nail seal set of the present embodiment, a pattern or the like can be drawn on the surface to give a decorative property. For this purpose, a seal containing a drug and a seal not containing a drug are prepared. Apply a seal that contains a drug to fingers infected with onychomycosis, and use a seal that does not contain drugs for fingers that do not have nail ringworm. Is possible.

  In the thirteenth embodiment, the nail seal 3 is effective not only as a treatment for ringworm on the nail but also as an ornament for making the fingertips look beautiful. Note that the nail seal 3 may be plain, and a decorated decoration seal may be separately prepared, and the nail seal 3 may be decorated with the decoration seal.

  The artificial nail 1 or the nail seal 3 in the above-described embodiment can be applied to both the nail of the hand and the nail of the foot. In addition, a plurality of artificial nails 1 having different sizes may be prepared, and the artificial nail 1 may be used according to the size of the nail of the hand or the toenail. Further, a set for five fingers as in the thirteenth embodiment may be realized by an artificial nail.

The technical features (components) described in each embodiment can be combined with each other, and new technical features can be formed by combining them.
The embodiments disclosed herein are illustrative in all respects and should not be considered as restrictive. The scope of the present invention is defined not by the above-mentioned meaning but by the scope of the claims, and is intended to include all modifications within the meaning and scope equivalent to the scope of the claims.

DESCRIPTION OF SYMBOLS 1 Artificial nail 11 Main body layer 113 Protrusion part 12 Drug layer 13 Protrusion part 131 Drug introduction path 132 Discharge hole 14 Drug holding part 15 Adhesive layer 2 Case 21 Entry part 3 Nail seal 31 Protective layer 32 Main body layer 33 Drug layer 34 Adhesive layer 35 Protruding part 36 Drug holding part 4 Seal mount

Claims (6)

A sheet-like main body,
An adhesive layer provided on the lower surface of the main body ,
A plurality of holding portions each having an outer shell formed of a sheet or a film and a medicine held inside the outer shell;
It has a tapered shape, a root portion is bonded to the adhesive layer, and includes a plurality of protrusions having a hole at the tip ,
Each of the plurality of projecting portions accommodates the holding portion inside the root portion.
A nail seal characterized by that. The nail seal according to claim 1, wherein the nail seal has a crescent shape in plan view. The nail seal according to claim 1 or 2, wherein an adhesive is applied to only a part of the adhesion surface of the adhesive layer to the nail. The adhesion surface to the nail | claw of the said adhesion layer consists of several area | regions, and the adhesive agent from which adhesive force differs is apply | coated to each area | region. Nail seal as described. A sheet having a sheet shape and having a plurality of nail seals according to any one of claims 1 to 4. The seal sheet according to claim 5, further comprising a recording unit that records a use start date of the nail seal.

Images